Position
Chief Financial Officer
Company
Halozyme Therapeutics
San DiegoManufacturingBiotechnologyHealth CarePharmaceuticalBiopharmaDescription
Halozyme Therapeutics, Inc. announces the appointment of David Ramsay as Interim Chief Financial Officer, effective March 23, 2026. Ramsay will oversee all financial operations while the company searches for a permanent CFO.
Quick answer
Halozyme Appoints David Ramsay as Interim Chief Financial Officer (March 12, 2026). Halozyme Therapeutics is based in San Diego, California, United States.
- Who is the new Chief Financial Officer at Halozyme Therapeutics?
- Halozyme Therapeutics named David Ramsay Chief Financial Officer, announced March 12, 2026.
- What did Halozyme Therapeutics announce on March 12, 2026?
- Halozyme Therapeutics, Inc. announces the appointment of David Ramsay as Interim Chief Financial Officer, effective March 23, 2026. Ramsay will oversee all financial operations while the company searches for a permanent CFO.
- What does Halozyme Therapeutics do?
- Halozyme is a biopharmaceutical company advancing disruptive solutions to improve patient experiences and outcomes for emerging and established therapies.
- Where is Halozyme Therapeutics based?
- Halozyme Therapeutics is based in San Diego, California, United States.
- Which similar companies made leadership changes around the same time?
- Bristol Myers Squibb (February 9, 2026), MBX Biosciences, Inc. (March 10, 2026), Santhera Pharmaceuticals (March 10, 2026) and Atossa Therapeutics (March 19, 2026) also announced leadership changes within 45 days of Halozyme Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Pharmaceutical and Biopharma
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Bristol Myers Squibb Appoints Harald Hampel as Senior VP Worldwide Head of Medical Affairs. (February 9, 2026)
- MBX Biosciences Appoints Karen Basbaum as Chief Business Officer (March 10, 2026)
- Santhera Pharmaceuticals Appoints Marc Clausse as Chief Commercial Officer (March 10, 2026)
- Atossa Therapeutics Appoints Kathy Puyana Theall and Adebola Giwa as Medical Directors (March 19, 2026)
- Aquestive Therapeutics Announces Departure of Chief Legal Officer (March 20, 2026)
- PCCA Appoints Matthew Line as Chief Marketing Officer (March 3, 2026)
Who to call at Halozyme Therapeutics, and when
A new leader at Halozyme Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Halozyme Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Halozyme Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Halozyme Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Halozyme Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Halozyme Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.